152 related articles for article (PubMed ID: 17331732)
1. Identification of antitumour activity of novel derivatives of 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione and 8-aryl-4-imino-2,3,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3(6H)-one.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M; Dybała I; Kozioł AE
Bioorg Med Chem; 2007 Apr; 15(8):2837-49. PubMed ID: 17331732
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
3. Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Dec; 41(12):1373-84. PubMed ID: 16996655
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate.
Sztanke M; Rzymowska J; Sztanke K
Bioorg Med Chem; 2013 Dec; 21(23):7465-80. PubMed ID: 24126095
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure elucidation, determination of the lipophilicity and identification of antitumour activities in vitro of novel 3-(2-furanyl)-8-aryl-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones with a low cytotoxicity towards normal human skin fibroblast cells.
Sztanke K; Tuzimski T; Sztanke M; Rzymowska J; Pasternak K
Bioorg Med Chem; 2011 Sep; 19(17):5103-16. PubMed ID: 21839643
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure elucidation and identification of antiproliferative activities of a novel class of thiophene bioisosteres bearing the privileged 7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-one scaffold.
Sztanke M; Rzymowska J; Sztanke K
Bioorg Med Chem; 2015 Jul; 23(13):3448-56. PubMed ID: 25975637
[TBL] [Abstract][Full Text] [Related]
9. Identification of antibacterial and antiviral activities of novel fused 1,2,4-triazine esters.
Sztanke K; Pasternak K; Rajtar B; Sztanke M; Majek M; Polz-Dacewicz M
Bioorg Med Chem; 2007 Aug; 15(16):5480-6. PubMed ID: 17572093
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new derivatives of 8-aryl-3-phenyl-6,7-dihydro-4H-imidazo[2, 1-c][1,2,4]triazin-4-one.
Sztanke K
Acta Pol Pharm; 2004; 61(5):373-7. PubMed ID: 15747694
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones.
Sztanke K; Pasternak K; Sztanke M; Kandefer-Szerszeń M; Kozioł AE; Dybała I
Bioorg Med Chem Lett; 2009 Sep; 19(17):5095-100. PubMed ID: 19631534
[TBL] [Abstract][Full Text] [Related]
12. Lipophilicity of novel antitumour and analgesic active 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione derivatives determined by reversed-phase HPLC and computational methods.
Sztanke K; Markowski W; Swieboda R; Polak B
Eur J Med Chem; 2010 Jun; 45(6):2644-9. PubMed ID: 20172631
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)- 1,3,5-triazine derivatives.
Pomarnacka E; Bednarski P; Grunert R; Reszka P
Acta Pol Pharm; 2004; 61(6):461-6. PubMed ID: 15794339
[TBL] [Abstract][Full Text] [Related]
15. SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF NEW FUSED TRIAZINE DERIVATIVES BASED ON 6-METHYL-3-THIOXO-1,2,4-TRIAZIN-5-ONE.
Abd El-All AS; Hassan AS; Osman SA; Yosef HA; Abdel-Hady WH; El-Hashash MA; Atta-Allah SR; Ali MM; El Rashedy AA
Acta Pol Pharm; 2016; 73(1):79-92. PubMed ID: 27008803
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of imidazoline and imidazo[2,1-c][1,2,4]triazole aryl derivatives containing the methylthio group as possible antibacterial agents.
Sztanke K; Pasternak K; Sidor-Wójtowicz A; Truchlińska J; Jóźwiak K
Bioorg Med Chem; 2006 Jun; 14(11):3635-42. PubMed ID: 16455261
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some novel substituted purine derivatives as potential anticancer, anti-HIV-1 and antimicrobial agents.
Rida SM; Ashour FA; El-Hawash SA; El-Semary MM; Badr MH
Arch Pharm (Weinheim); 2007 Apr; 340(4):185-94. PubMed ID: 17351964
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F
Eur J Med Chem; 2002 Sep; 37(9):709-20. PubMed ID: 12350288
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A; Bednarski P; Grunert R
Eur J Med Chem; 2006 Feb; 41(2):219-25. PubMed ID: 16377034
[TBL] [Abstract][Full Text] [Related]
20. The influence of substituents on the reactivity and cytotoxicity of imidazothiazolotriazinones.
Gazieva GA; Izmest'ev AN; Anikina LV; Pukhov SA; Meshchaneva ME; Khakimov DV; Kolotyrkina NG; Kravchenko AN
Mol Divers; 2018 Aug; 22(3):585-599. PubMed ID: 29542013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
